Focus: Hidden - Houston Metro

Filters close
20-Feb-2018 5:05 PM EST
Kinase Inhibitor Larotrectinib Shows Durable Anti-Tumor Abilities in Patients of All Ages with 17 Unique Cancer Diagnoses
University of Texas MD Anderson Cancer Center

Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses.

Released: 20-Feb-2018 2:05 PM EST
Harris Health Awarded First-Ever Gold Workplace Health Achievement
Harris Health System

The American Heart Association (AHA) awarded Harris Health System its first-ever Gold level Workplace Health Achievement for creating and implementing successful health programs for employees in the workplace. This award echoes AHA’s mission of building healthier lives free of cardiovascular disease and stroke.

12-Feb-2018 8:05 AM EST
Obesity Associated with Longer Survival for Men with Metastatic Melanoma
University of Texas MD Anderson Cancer Center

Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts. This effect, referred to as the “Obesity Paradox”, principally manifested itself in men, said Jennifer McQuade, M.D., lead author and instructor of Melanoma Medical Oncology at The University of Texas MD Anderson Cancer Center.

12-Feb-2018 10:05 AM EST
Smart Bomb Virus Shows Promise as Brain Tumor Immunotherapy
University of Texas MD Anderson Cancer Center

A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center report on a phase I clinical trial in the Journal of Clinical Oncology.

9-Feb-2018 12:00 PM EST
Newly Identified Potential Therapeutic Approach Kills Triple-Negative Breast Cancer Cells in Pre-Clinical Study
University of Texas MD Anderson Cancer Center

Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone cancer that accounts for one-fourth of all breast cancers, could be the focus of a new area of study for immune checkpoint blockade therapy. A team of researchers at The University of Texas MD Anderson Cancer Center revealed that in TNBC a cell process called glycosylation is required for PD-L1/PD1 molecules to interact and identified exactly how and why glycosylation is so crucial.

Released: 8-Feb-2018 5:05 PM EST
UTHealth Leads ACSM Paper on Safety Recommendations for Energy Drinks
University of Texas Health Science Center at Houston

Helpful guidance and warnings regarding the potential dangers that energy drinks present to at-risk populations, primarily children, were published in a paper led by a cardiologist at The University of Texas Health Science Center at Houston (UTHealth) for the American College of Sports Medicine (ACSM).

30-Jan-2018 11:00 AM EST
MD Anderson Study Evaluates Need for Biopsies During Follow-Up Care in Women with Early Breast Cancer
University of Texas MD Anderson Cancer Center

In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed for these patients during their follow-up care. The findings, reported in JAMA Surgery, are the first comprehensive nationwide population-based study regarding the need for breast biopsies performed during follow up after treatment for invasive breast cancer.

Released: 24-Jan-2018 12:05 PM EST
Houston Methodist Hospital Reaches Heart Transplant Milestone
Houston Methodist

Houston Methodist Hospital performed its 1000th heart transplant. The hospital's first was performed by Dr. Michael DeBakey in 1968 as part of the world's first multi-organ transplant. The patient is a 23-year old man who suffers from Becker's Muscular Dystrophy, a rare form of the disease that damages the heart.

16-Jan-2018 10:05 AM EST
Presurgical Targeted Therapy Delays Relapse of High-Risk Stage 3 Melanoma
University of Texas MD Anderson Cancer Center

A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at The University of Texas MD Anderson Cancer Center report in Lancet Oncology. Patients who had no sign of disease at surgery after combination treatment did not progress to metastasis.

Released: 17-Jan-2018 11:05 AM EST
National Academy of Sciences Awards Kovalenko Medal to Immunotherapy Pioneer Allison
University of Texas MD Anderson Cancer Center

Cancer immunotherapy innovator Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, will receive the 2018 Jessie Stevenson Kovalenko Medal for outstanding research in medical sciences, the National Academy of Sciences announced today.

Released: 9-Jan-2018 6:05 PM EST
Tiny Antibiotic Beads Fight Infections After Joint Replacement
Houston Methodist

More than 1 million people undergo total joint replacements each year, and nearly 10,000 will develop infections. To reduce this infection risk, a Houston Methodist orthopedic surgeon created small antibiotic beads that are implanted with the new joint to slowly release medicine for several weeks.

Released: 8-Jan-2018 5:05 PM EST
Plan for UTHealth Continuum of Care Campus for Behavioral Health Announced with State’s Approval of Initial Funds
University of Texas Health Science Center at Houston

With the first $6 million in state funds approved for the construction of a psychiatric hospital in Houston, UTHealth will oversee construction of a continuum of care campus for behavioral health that addresses a critical need in Texas.

3-Jan-2018 12:05 PM EST
New Cancer Model Shows Genomic Link Between Early-Stage and Invasive Breast Cancer Types
University of Texas MD Anderson Cancer Center

A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson Cancer Center.

3-Jan-2018 11:05 AM EST
Small-Cell Lung Cancer Patients Face Barriers to Receiving Standard-of-Care Treatment
University of Texas MD Anderson Cancer Center

Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients do not receive these treatments and in turn have lower overall survival, according to research from The University of Texas MD Anderson Cancer Center.

Released: 13-Dec-2017 3:45 PM EST
Brain Illness that Crippled Teen Isn’t Defining his Future
Harris Health System

Comatose and unable to talk for nearly a year and half, a 24-year-old is again living a normal life. Harris Health System's medical team identified his condition as anti-N-methyl D-aspartate receptor encephalitis (anti-NMDA), a rare, and sometimes, difficult disease to identify and properly treat.

Released: 13-Dec-2017 10:05 AM EST
UTHealth Study Finds That Male Virgins Can Still Acquire HPV
University of Texas Health Science Center at Houston

Men who have never engaged in sexual intercourse are still at risk for acquiring HPV, according to a study published recently in the Journal of Infectious Diseases by researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.

Released: 13-Dec-2017 1:00 AM EST
Treatable Condition Could Be Mistaken for Schizophrenia or Bipolar Disorder
Houston Methodist

Researchers at Houston Methodist believe that a significant number of people diagnosed with schizophrenia or bipolar disorder may actually have a treatable immune system condition. A new research study could have a significant impact on the millions diagnosed with schizophrenia or bipolar disorder, including many homeless.

Released: 12-Dec-2017 10:05 AM EST
UTHealth Researchers Link Epigenetic Aging to Bipolar Disorder
University of Texas Health Science Center at Houston

Bipolar disorder may involve accelerated epigenetic aging, which could explain why persons with the disorder are more likely to have – and die from – age-related diseases, according to researchers from McGovern Medical School at UTHealth Houston.

10-Dec-2017 12:00 PM EST
AML Study Reports High Response Rates with Combination Targeted Therapy
University of Texas MD Anderson Cancer Center

Initial findings from a multi-national open-label phase Ib study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response in up to 50 percent patients say researchers at The University of Texas MD Anderson Cancer Center .

9-Dec-2017 10:30 AM EST
Phase 2 CAR-T Study Reports Significant Remission Rates at 15-Month Follow Up
University of Texas MD Anderson Cancer Center

A study involving the recently approved CD19-targeting chimeric antigen receptor (CAR) T cell therapy shows that 42 percent of patients with aggressive large B-cell lymphoma remained in remission at 15 months following treatment with axi-cel (marketed as Yescarta™).

Released: 8-Dec-2017 9:05 AM EST
PARP Inhibitor Improves Progression-Free Survival in Patients with Advanced Breast Cancers and BRCA Mutations
University of Texas MD Anderson Cancer Center

In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

Released: 7-Dec-2017 8:05 AM EST
Ribociclib Extends Progression-Free Survival in Pre-Menopausal Patients with Metastatic Hormone Receptor-Positive Breast Cancer
University of Texas MD Anderson Cancer Center

The addition of ribociclib, an inhibitor of the cell cycle, to standard hormone therapy significantly improved progression-free survival (PFS) in pre-menopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

5-Dec-2017 1:00 PM EST
Novel Regulation of Gene Expression in Brain Tumors Identified
University of Texas MD Anderson Cancer Center

Study results revealed previously unknown interplay between two key enzymes and a novel understanding of how brain cancer tumors form and spread, according to researchers at The University of Texas MD Anderson Cancer Center.

Released: 1-Dec-2017 11:05 AM EST
MD Anderson to Present Key Drug Study Findings for Multiple Blood Cancers at ASH Annual Meeting
University of Texas MD Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center will present their latest findings involving drug treatments for blood cancers at the American Society of Hematology’s (ASH) Annual Meeting & Exposition Dec. 8-12 in Atlanta.

Released: 30-Nov-2017 7:05 PM EST
Tips for a Safe, Enjoyable Holiday Trip for Families with Disabilities
Houston Methodist

The holiday season is filled with travel as many families drive or fly to spend time with loved ones, but traveling with a disability can create unique challenges for some families.

Released: 29-Nov-2017 4:05 PM EST
UTHealth’s Margo Melchor Appointed to Texas State Board of Dental Examiners
University of Texas Health Science Center at Houston

Margo Melchor, R.D.H., M.Ed., Ed.D., community outreach director for the School of Dentistry at The University of Texas Health Science Center at Houston (UTHealth), has been appointed to the Texas state board that regulates the practice of dentistry and dental hygiene.

Released: 28-Nov-2017 11:05 AM EST
Stress Causes Stress on Hearts
Houston Methodist

People who have lived though natural disasters such as Hurricane Harvey are under a great amount of stress putting their lives back together. A cardiologist tells us that this type of stress, in a roundabout way, can do damage to the heart.

Released: 27-Nov-2017 11:05 AM EST
MD Anderson Applauds Court-Ordered Corrective Statements From Tobacco Industry to Educate Public About Harms of Tobacco Use
University of Texas MD Anderson Cancer Center

As an institution dedicated to ending cancer, The University of Texas MD Anderson Cancer Center is committed to promoting cancer prevention and therefore supports the ‘corrective statements’ published by tobacco companies as a result of a 2006 judgment by U.S. District Judge Gladys Kessler. The mandated advertisements, which began appearing this week, will be a significant step toward informing Americans about the addictive power of cigarettes and the harms of tobacco use.

Released: 27-Nov-2017 11:05 AM EST
UT Physicians Offers Five Ways to Stay Healthy During Holiday Travel
University of Texas Health Science Center at Houston

Holiday travel can take a toll on your health if you are not careful, according to Amy Laude, M.D., a family medicine practitioner with UT Physicians, the clinical practice of McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

Released: 22-Nov-2017 10:05 AM EST
Have Yourself a Safe Holiday Shopping Season
University of Texas Health Science Center at Houston

While hunting down the perfect gift for Aunt Sally or rushing to whip up a revered family recipe, the last thing on your mind this holiday season might be your safety and security.

Released: 21-Nov-2017 4:05 PM EST
UTHealth Executive Elected as a 2017 AAAS Fellow
University of Texas Health Science Center at Houston

Michael R. Blackburn, Ph.D., a nationally recognized lung disease researcher and academic leader at The University of Texas Health Science Center at Houston (UTHealth), has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as a Fellow is an honor bestowed upon AAAS members by their peers.

Released: 21-Nov-2017 3:55 PM EST
UTHealth Holds Mass Casualty Incident to Prepare Students for the Worst
University of Texas Health Science Center at Houston

Screams were heard as a runaway car plowed through a crowd before the vehicle crashed and the wreckage was engulfed in flames. The chaos was heightened by the sirens from fire trucks and ambulances rushing to the scene. After firefighter cadets from the Houston Fire Department (HFD) subdued the flames, more than 300 students and volunteers from The University of Texas Health Science Center at Houston (UTHealth) rushed onto the smoky field, ready to triage and respond to those injured in the accident.

20-Nov-2017 11:00 AM EST
Six Researchers From MD Anderson Elected as AAAS Fellows
University of Texas MD Anderson Cancer Center

In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS).

13-Nov-2017 5:05 PM EST
Quality of Care for Older Texas Patients with Colon Cancer on the Rise, Still Room for Improvement
University of Texas MD Anderson Cancer Center

Research from The University of Texas MD Anderson Cancer Center finds adherence to surgical treatment guidelines has improved significantly among older Texas patients with colon cancer since 2001, while adherence to chemotherapy guidelines has remained largely unchanged. The study, published today in Cancer, identifies factors influencing adherence rates, including socioeconomic status and access to skilled physicians.

15-Nov-2017 11:30 AM EST
UTHealth Celebrates Landmark Gift to Provide Unprecedented Resources to Its Nursing School
University of Texas Health Science Center at Houston

Jane and Robert Cizik have made a landmark gift of $25 million to the School of Nursing at The University of Texas Health Science Center at Houston (UTHealth), giving the school the resources and capacity to shape the future of nursing education and health care delivery.

Released: 14-Nov-2017 5:05 PM EST
UTHealth Experts Offer Tips on Surviving – and Enjoying – Family During the Holidays
University of Texas Health Science Center at Houston

During the holidays, throwing together a dozen (or 50) assorted personalities is already stressful enough. Add to that the desire to make it picture-perfect and Pinterest-worthy and things really get tough. UTHealth Houston experts can tell you how to survive!

Released: 14-Nov-2017 12:05 PM EST
Team Approach Helps Patients Regain Control of Diabetes
Harris Health System

Before diabetes takes or disables a life, Harris Health System wants to step in. Through an ambitious program that places patients with uncontrolled diabetes with a team of medical experts and support staff, the aim is to change the course of the disease in dramatic fashion.

Released: 14-Nov-2017 12:05 PM EST
Harris Health RNs Listed Among Top 20 in Houston by Texas Nurses Association
Harris Health System

Two Harris Health System nurses are among the 20 Outstanding Nurses for 2017, an award given by the Texas Nurses Association, District 9. The pair joins honorees nominated by peers and coworkers as exemplary registered nurses from greater Houston.

Released: 9-Nov-2017 11:05 AM EST
Save Yourself the Holiday Food Stress with 8 Simple Healthy Eating Strategies
University of Texas Health Science Center at Houston

When an average slice of pumpkin pie and scoop of vanilla ice cream can contain 46 grams of sugar – nearly twice the recommended daily added sugar intake of 25 grams for women and well above the recommendation of 36 grams for men– the holidays can be hazardous for anyone watching their waistlines.

Released: 9-Nov-2017 11:05 AM EST
Avoid Foodborne Illness This Holiday Season with Tips From UTHealth Experts
University of Texas Health Science Center at Houston

This holiday season, think twice before you do that late-night nibbling at the buffet table, particularly if it has been sitting out for a while. One bite of crab dip or deviled eggs gone bad, and you may be moving your holiday festivities to the bathroom — or the hospital.

7-Nov-2017 4:55 PM EST
Chronic Stress Hormones May Promote Resistance to EGFR Inhibitors in Lung Cancer Patients
University of Texas MD Anderson Cancer Center

Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used to treat lung cancer patients with EGFR mutations, according to new research from The University of Texas MD Anderson Cancer Center. Retrospective analysis of clinical patient data suggests that beta blocker drugs may slow or prevent the development of resistance to EGFR inhibitors.

Released: 7-Nov-2017 9:05 AM EST
Study Outlines ‘Perfect Storm’ That Led to Colombia’s Antibiotic Resistance Epidemic
University of Texas Health Science Center at Houston

The nearly simultaneous emergence of a gene responsible for producing carbapenemases - enzymes that kill the most powerful antibiotics used against life-threatening, multidrug-resistant bacterial infections - coupled with the introduction of a bacterial clone that spread between patients created the “perfect storm” that led to today’s antibiotic resistance epidemic in Colombia.

Released: 7-Nov-2017 9:00 AM EST
Circulating Tumor Cells Associated with Relapse in Late-Stage Melanoma Patients
University of Texas MD Anderson Cancer Center

A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as a potential predictor of patients at high risk for disease progression. CTCs, tumor cells shed into the bloodstream or lymphatic system, can lead to additional tumor growth and/or metastasis to distant sites. Findings from the study, led by Anthony Lucci, M.D., professor of Breast Surgical Oncology and Surgical Oncology at The University of Texas MD Anderson Center, will be presented at the Nov. 7 annual meeting of the Western Surgical Association.

Released: 6-Nov-2017 12:30 PM EST
Age-Old Malaria Treatment Found to Improve Nanoparticle Delivery to Tumors
Houston Methodist

A new study shows that a 70-year-old malaria drug can block immune cells in the liver so nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of targeted drug delivery, according to a team of researchers led by Houston Methodist.

   
5-Nov-2017 11:00 AM EST
MD Anderson’s Moon Shots Program Celebrates Five-Year Anniversary
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center celebrates the five-year anniversary of its Moon Shots Program™, a collaborative effort to accelerate the development of scientific discoveries into clinical advances that save patients’ lives. Launched in the fall of 2012, the program already has yielded notable discoveries across the spectrum of cancer care, including prevention, early detection and treatment, and has inspired philanthropic support totaling more than $451 million.

1-Nov-2017 12:05 PM EDT
Bacteria in the Gut Modulates Response to Immunotherapy in Melanoma
University of Texas MD Anderson Cancer Center

Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science.

Released: 31-Oct-2017 4:55 PM EDT
UTHealth, Adult Protective Services Join Forces to Improve Lives of Texas Elderly
University of Texas Health Science Center at Houston

The Texas Forensic Assessment Center Network (FACN) has been expanded from children’s services to include adults through a formal agreement between the Texas Department of Family and Protective Services (DFPS) and McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

Released: 31-Oct-2017 4:40 PM EDT
UTHealth Receives $2.5 Million for HIV Education and Treatment for Persons with Substance Use Disorders
University of Texas Health Science Center at Houston

A $2.5 million federal grant will allow a multidisciplinary team at McGovern Medical School at UTHealth in Houston to provide prevention and treatment information about HIV, AIDS and sexually transmitted diseases to underserved individuals with substance abuse or mental disorders.

Released: 26-Oct-2017 12:05 PM EDT
Dream Team Aims to Intercept Pancreatic Cancer Before It Flourishes
University of Texas MD Anderson Cancer Center

Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest to defeat. A Dream Team assembled by Stand Up to Cancer and led by an investigator at The University of Texas MD Anderson Cancer Center will test new ways to find the disease in its emerging, more vulnerable phase in people who are at high risk for developing it.

Released: 19-Oct-2017 4:30 PM EDT
Hurricane Harvey Forces LBJ Hospital Surgeon to Perform First-Ever Brain Surgery
Harris Health System

As Hurricane Harvey battered Houston, dumping more than 51 inches of rain, the medical team at Lyndon B. Johnson Hospital performed its first life-saving brain surgery on patient. The team, led by a colorectal surgeon, cobbled together tools and equipment for a successful procedure.



close
1.09192